ANTIMICROBIAL HOOK AND LOOP FASTENER
FIELD OF THE INVENTION
This invention relates to a hook and loop fastener containing an antimicrobial agent.
BACKGROUND OF THE INVENTION
Hook and loop fasteners, of which VELCRO® is one type, are well known and versatile consumer items. Hook and loop fasteners may become contaminated with bacteria, fungi, and other microorganisms directly, for example
from exposure during the course of use, and/or indirectly, for example by cross- contamination, whereby attachment or detachment exposes the fastener to
microorganisms transferred from contaminated hands. Once contaminated, they become a veritable breeding ground for microorganisms, similar to wall-to-wall carpeting.
Hook and loop fasteners such as VELCRO® have been used in a
wide variety of consumer products. Hook and loop fasteners are used in a broad range of medical products, such as in bandages or other wound dressing, hospital
gowns, nurses' uniforms, surgical gowns, and uniforms used in manufacturing facilities requiring highly sanitary conditions.
Attempts have been made to develop hook and loop fasteners which exhibit antimicrobial action at all times. For example, Japanese Abstract No. 06141914 discloses a fastener of a hook and loop configuration containing thiosulfate silver complex which is said to act as an antibacterial agent. The agent is kneaded into the component filaments and spinning yarn prior to assembly of the fastener.
U.S. Patent No. 5,727,677 discloses chemically treated VELCRO® strips said to impart resistance from infection.
U.S. Patent No. 5,180,585 discloses an antimicrobial powder
composition containing a metallic coating as the antimicrobial ingredient, which is said to impart biocidal properties when incorporated into polymeric articles such as fibers.
The component added to the hook and loop fastener for imparting antimicrobial action must address certain needs. For example, the component should be convenient to blend into or coat onto the filament of the fastener. In
addition, the component should not interfere with engagement of the hook and
loop fastener material (e.g., it should not cause fatigue and subsequent cracking of the filament). Since hook and loop fasteners are used extensively in laboratories and in hospitals, the antimicrobial component should not be harmful to the human body and should maintain consistent efficacy over the useful life of the article to which the fastener is affixed. Further, since hook and loop fasteners are
commonly part of disposable consumer items, the antimicrobial component should not generate harmful agents upon disposal.
The component also must not lead to fatiguing of the polymer composition. Generally, particles of greater than 2 microns in diameter will cause fatiguing when added to polymeric compositions.
At first glance, various types of organic antimicrobial compounds
would appear to be applicable for achieving the desired goals. However, use of many such compounds is inherently problematic. For example, liquid organic agents are difficult to blend into the filaments of the fastener, do not maintain effectiveness over time, and have been considered to contribute to filament fatigue. Also, microbes have been found to develop resistance to organic
antimicrobial agents, and organic agents induce skin irritation in a substantial number of cases. The efficacy of organic antimicrobial agents (e.g., triclosan)
declines over time as the active agent leaches out of the substrate. Furthermore, organic antimicrobial agents often have toxic decomposition products (e.g., triclosan is believed to generate dioxin when burned), creating environmental
problems on disposal.
The present invention uses antimicrobial agents, such as silver ion-
containing zeolite, which provides quick, non-toxic antimicrobial action over a period of time without inducing microbial resistance, or causing toxicity or irritation. The use of a silver-containing composition in particular allows non-toxic and
effective hook and loop fasteners to be formulated.
OBJECTS OF THE INVENTION
Accordingly, an object of the present invention is to provide a hook and loop fastener containing an antimicrobial agent.
It is another object of the present invention to provide a hook and
loop fastener containing an antimicrobial agent which is nontoxic and safe for
human contact
Yet another object of the present invention is to provide a hook and loop fastener containing an antimicrobial agent that does not generate toxins on disposal.
SUMMARY OF THE INVENTION
The invention is directed to a hook and loop fastener, comprising a
hook element and a loop element, which comprises a polymeric composition. At least one of the hook or loop elements of the fastener comprises particles which contain or carry antimicrobial metal cations in an effective amount to impart antimicrobial property to the fastener. In preferred embodiments, the particles are
inorganic particles, e.g. inorganic ceramic particles such as zeolite.
In one embodiment, the polymeric composition of the fastener may be coated with a composition comprising the inorganic antimicrobial agent. In
other embodiments, the inorganic antimicrobial composition may be blended in the masterbatch of the polymer composition which forms the hook and loop fastener.
The antimicrobial ceramic particles are preferably approximately 1-2 microns in diameter.
DETAILED DESCRIPTION OF THE INVENTION
1. Antibacterial hook and loop fastener:
The present invention is directed to a hook and loop fastener containing an
inorganic antimicrobial agent composition.
As used herein, the term "hook and loop" is given its ordinary meaning,
and includes hook and loop fasteners made from polymeric compositions, fibers or
filaments. The filament comprising the hook and loop material may comprise nylon,
polyester or other polymeric substances. Polymeric compositions used to form the hook
and loop fasteners may contain, for example, plasticizers, colorants, fillers, anti-oxidants
and UV-stabilizers. Suitable hook and loop fasteners are those sold under the name
VELCRO®, manufactured by the Velcro Company.
The hook and loop may but need not be of the same composition.
Typically, smaller fibers are used to form loops, and larger fibers are used to form hooks.
The hooks and fibers may then be woven or stitched into backings, which may also be
formed from a polymeric composition.
As used herein, the term "effective amount" is used synonymously with
"sufficient amount", both terms referring to the amount of active ingredient in the hook
and loop fastener of the invention required to achieve the antimicrobial properties thereof.
This amount is at least equal to MBC (minimum biocidal content, i.e. , the content
necessary to kill 99.9% of an inoculum of microbes within 24 hours of inoculation) when
a biocidal effect is desired (or MIC (minimum inhibitory content) when an effect that is
merely inhibitory of microbial growth is desired) . The MBC or MIC of an antimicrobial
agent is used to evaluate the efficacy of the agent in vitro. The MIC is defined as the
minimum concentration in micrograms/ml of antimicrobial agent required for inhibiting
the growth of each type of microorganism. The smaller the MIC value, the greater the
efficacy of the antimicrobial agent. The assay for determining MIC is known, and can be
carried out by smearing a solution containing a particular microorganism for inoculation
onto a plate culture medium to which a test sample of antimicrobial compound of the
invention is added in a particular concentration, followed by incubation and culturing of
the plate. In such a test, the following microorganisms, for example, may be employed:
Streptococcus mutatis, porphyromonas gingivalis, Bacillus cereus var mycoides,
Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus
faecalis, Aspergillus niger, Aureobasidium pullulans, Chaetomium globosum,
Gliocladium virens, Penicillum fimiculosum, Candida albicans, and Saccharomyces
cerevisiae.
As used herein, the term "biocompatible" means compatible with and non-
toxic to the human body, in the context of a use being contemplated. In other words, the
degree of required biocompatibility for an ingestible use is greater than for something that merely touches the skin.
The method used to impart bactericidal activity to the hook and loop
fastener may be done by introducing the antimicrobial agent into the master batch
formulation of the filament. Alternatively, it can be applied post- formulation. The
antimicrobial agent may be uniformly distributed throughout the hook and loop filaments,
as well as throughout the base material on which the filaments are attached. It is
understood that the agent must be present in an effective amount, i.e. , in sufficient
concentration to kill microbes that may come in contact with the fastener, or to resist the
growth of microbes in, or between the fibers of the fastener.
In a preferred embodiment, the antimicrobial agent may be kneaded into
the polymeric composition used to form the fastener. A binder may also be present to aid
in the incorporation of the antimicrobial agent. The agent may be incorporated into the
polymeric composition before spinning into the fiber.
In another embodiment, the inorganic antimicrobial agent is sprayed onto
the surface of the hook and loop fastener of the invention. The inorganic antimicrobial
agent is preferably formed with a binder to create a dispersion which is sprayed or coated
on the fastener. Examples of binders that can be used include methyl cellulose, methyl
methacrylate, and cellulose acetate phthalate. The particular binder is selected so that it
is compatible with the polymeric composition of the hook and loop fastener. The
dispersion is then sprayed or coated onto the binder.
The content of antimicrobial zeolite is incorporated into the filament batch
during formulation is 0.1 to 20% by weight, preferably 0.5 to 10% by weight, and most
preferably 0.5 to 5 % by weight, e.g. about 3 % . The concentration of antimicrobial
zeolite for spray coating onto an already formed filament is 0.1 to 100% by weight,
preferably 0.5 to 75 % by weight, and most preferably 0.5 to 50% by weight. Weight %
as used herein is determined for materials dried in the conventional manufacturing drying
process.
Care must be taken so that the incorporation of the particles into the resin
does not damage the mechanical properties of the polymeric composition, i.e. cause
fatigue or elongation to failure, or weaken the impact properties . Particles of 10 microns
or greater may cause mechanical failure. Thus, it is preferred that the antimicrobial
particles do not exceed 10 microns in size. Preferred particles are those of 5 microns or
less, and most preferred are those of about 1-2 microns.
It is also important that a high degree of dispersion be obtained, so that the
antimicrobial particles are well-dispersed in the polymeric composition. Suitable
dispersion may be obtained by using any of the instruments typically used to obtain a high
degree of dispersion, such as a twin screw extruder.
Once the inorganic antimicrobial particles are compounded into the
polymeric composition in a suitable amount, the composition may be formed into a hook
and loop fastener by any of the methods commonly used in the art. Typically, the
polymeric composition is spun into fibers of varying size. Smaller fibers may be used to
form hooks, whereas the longer fibers are woven to form loops. The backing is also
generally formed from the polymeric fibers. The fibers may then be formed into hook
and loop fasteners by any of the methods commonly done in the art, such as by the
methods described in U.S. Patents Nos. 3,943,981 to De Brabander; 4,271 ,566, to
Perina; 4,794,028, to Fischer; 5,436,051, to Donaruma et al. ; 5,457,855 to Kenney et
al., and 5,755,016 to Provost, all of which are hereby incorporated by reference.
B. Antimicrobial agent:
The preferred antimicrobial agent is an inorganic antimicrobial metal-
containing composition. A number of metal ions have been shown to possess
antimicrobial activity, including silver, copper, zinc, mercury, tin, lead, bismuth,
cadmium, chromium and thallium ions. These antimicrobial metal ions are believed to
exert their effects by disrupting respiration and electron transport systems upon
absorption into bacterial or fungal cells. Antimicrobial metal ions of silver, gold, copper
and zinc, in particular, are considered safe for in vivo use. Antimicrobial silver ions are
particularly useful for in vivo use due to the fact that they are not substantially absorbed
into the body.
One type of inorganic antimicrobial metal containing composition
contemplated by the invention is an antimicrobial metal salt. Such salts include silver
iodate, silver iodide, silver nitrate, and silver oxide. Silver nitrate is preferred. These
salts are particularly quick acting, as release from ceramic particles is necessary for the
fastener to have an effective amount of antimicrobial activity.
The ceramics employed in the antimicrobial ceramic particles of the
present invention include zeolites, hydroxyapatite, zirconium phosphates, or other ion-
exchange ceramics. Zeolites are preferred, and are described in the preferred
embodiments referred to below. Hydroxyapatite particles containing antimicrobial metals
are described, e.g. , in U.S. Patent No. 5,009,898. Zirconium phosphates containing
antimicrobial metals are described, e.g. , in U.S. Patent Nos. 5,296,238; 5,441,717; and
5,405,644.
Inorganic particles, such as the oxides of titanium, aluminum, zinc and
copper, may be coated with a composition which confers antimicrobial properties, for
example, by releasing antimicrobial metal ions such as silver ions, which are described,
e.g. , in U.S. Patent No. 5, 1890,585. Inorganic soluble glass particles containing
antimicrobial metal ions, such as silver, are described, e.g. in U.S. Patent Nos.,
5,766,611 and 5,290,544.
C. Zeolites:
Antimicrobial zeolites have been prepared by replacing all or part of the
ion-exchangeable ions in zeolite with ammonium ions and antimicrobial metal ions, as
described in U.S. Patent Nos. 4,938,958 and 4,911,898. Such zeolites have been
incorporated in antimicrobial resins (as shown in U.S. Patent Nos. 4,938,955 and
4,906,464) and polymer articles (U.S. Patent No. 4,775,585). Polymers including the
antimicrobial zeolites have been used to make refrigerators, dish washers, rice cookers,
plastic film, plastic cutting boards, vacuum bottles, plastic pails and garbage containers.
Other materials in which antimicrobial zeolites have been incorporated include flooring,
wall paper, cloth, paint, napkins, plastic automobile parts, catheters, bicycles, pens, toys,
sand, and concrete. Examples of such uses are described in U.S. Patents 5,714,445;
5,697,203; 5,562,872; 5,180,585; 5,714,430; and 5,102,401.
Either natural zeolites or synthetic zeolites can be used to make the
antimicrobial zeolites used in the present invention. "Zeolite" is an aluminosilicate
having a three dimensional skeletal structure that is represented by the formula: XM2/π-O-
AhO3-YSiO2-ZH2O. M represents an ion-exchangeable ion, generally a monovalent or
divalent metal ion, n represents the atomic valency of the (metal) ion, X and Y represent
coefficients of metal oxide and silica respectively, and Z represents the number of water
of crystallization. Examples of such zeolites include A-type zeolites, X-type zeolites,
Y-type zeolites, T-type zeolites, high-silica zeolites, sodalite, mordenite, analcite,
clinoptilolite, chabazite and erionite. The present invention is not restricted to use of
these specific zeolites.
The ion-exchange capacities of these zeolites are as follows: A-type zeolite
= 7 meq/g; X-type zeolite = 6.4 meq/g; Y-type zeolite = 5 meq/g; T-type zeolite =
3.4 meq/g; sodalite = 11.5 meq/g; mordenite = 2.6 meq/g; analcite = 5 meq/g;
clinoptilolite = 2.6 meq/g; chabazite = 5 meq/g; and erionite = 3.8 meq/g. These
ion -exchange capacities are sufficient for the zeolites to undergo ion-exchange with
ammonium and antimicrobial metal ions.
The specific surface area of preferred zeolite particles is preferably at least
150 m2/g (anhydrous zeolite as standard) and the Siθ2/AhO3 mol ratio in the zeolite
composition is preferably less than 14, more preferably less than 11. The antimicrobial
metal ions used in the antimicrobial zeolites should be retained on the zeolite particles
through an ion-exchange reaction. Antimicrobial metal ions which are adsorbed or
attached without an ion-exchange reaction exhibit a decreased bactericidal effect and their
antimicrobial effects are not long-lasting. Nevertheless, it is advantageous for imparting
quick antimicrobial action to maintain a sufficient amount of metal ions absorbed by the
surface of zeolite.
In the ion-exchange process, the antimicrobial metal ions (cations) tend to
be converted into their oxides, hydroxides, basic salts etc. either in the micropores or on
the surfaces of the zeolite and also tend to deposit there, particularly when the
concentration of metal ions in the vicinity of the zeolite surface is high. Such deposition
tends to adversely affect the bactericidal properties of ion-exchanged zeolite. This
undesirable deposition could be limited to acceptable levels or prevented by adjusting the
pH value of the solution to the range of 3 to 10.
In an embodiment of the antimicrobial zeolites, a relatively low degree of
ion exchange is employed to obtain superior bactericidal properties. At least a portion of
the zeolite particles should retain metal ions (cations) having bactericidal properties at
ion-exchangeable sites of the zeolite in an amount less than the ion-exchange saturation
capacity of the zeolite. In one embodiment, the zeolite employed in the present invention
retains antimicrobial metal ions in an amount up to 41 % of the theoretical ion-exchange
capacity of the zeolite. Such ion-exchanged zeolite with a relatively low degree of
ion-exchange may be prepared by performing ion-exchange using a metal ion solution
having a low concentration, for example 0.3 wt% , as compared with solutions
conventionally used for ion exchange.
In antimicrobial zeolite particles used in the present invention,
ion-exchangeable ions present in zeolite, such as sodium ions, calcium ions, potassium
ions and iron ions are preferably partially replaced with ammonium and antimicrobial
metal ions. Such ions may co-exist in the antimicrobial zeolite particle since they do not
prevent the bactericidal effect. While antimicrobial metal ions include ions of silver,
copper, zinc, mercury, tin, lead, bismuth, cadmium, chromium and thallium, edible
antimicrobial zeolites to be formulated into compositions to be used in the fastener of the
invention include silver, gold, copper and zinc ions. These antimicrobial metal ions can
be used by themselves or in a mixture.
The zeolite preferably comprises an integral discoloration agent such as
ion-exchanged ammonium. Although ammonium ions may be contained in the zeolite at a
concentration as high as about 20% by weight of the zeolite, it is desirable to limit the
content of ammonium ions to about 0.5 to about 2.5 % , more preferably from about 0.5 to
about 2.0% , and most preferably, from about 0.5 to about 1.5% by weight of the zeolite.
A preferred antimicrobial zeolite for use in the hook and loop fastener of
the invention is type A zeolite containing either a combination of ion-exchanged silver,
zinc, and ammonium or silver and ammonium. One such zeolite is manufactured by
Shinagawa Fuel Co. Ltd. (a/k/a Shinanen, Tokyo, Japan) under the product number AW-
10N and consists of 0.6% by weight of silver ion-exchanged in Type A zeolite particles
having a diameter of about 2.5μ. Another formulation, AJ-10N, consists of about 2% by
weight silver ion-exchanged in Type A zeolite particles having a diameter of about 2.5μ.
Another formulation, AW-80, contains 0.6% by weight of silver ion-exchanged in Type
A zeolite particles having a diameter of about l .Oμ. These zeolites preferably contain
about between 0.5% and 2.5% by weight of ion-exchanged ammonium. The zeolites are
often obtained in master batches of low density polyethylene, polypropylene, or
polystyrene, containing 20 wt. % of the zeolite.
D. Examples:
The present invention is explained in more detail with reference to the
following non-limiting examples.
Example 1
A nylon polymeric composition is compounded with a Shinagawa AW-80
particles. The AW-80 zeolite particles (in the form of a powder) have been subject to
ion-exchange with antimicrobial silver ions. A concentrate of 20% of AW-80 particles is
prepared in the nylon and compounding is begun by any of the methods commonly used
in the art, such as with any of the types of compounders commonly used in the prior art
to achieve a high degree of dispersion, i.e. a twin screw extruder. Thereafter, the
polymeric composition is diluted with additional amounts of nylon, to result in a
composition having about 3 % by weight antimicrobial zeolite particles.
The resulting polymeric composition is then spun into both large and small
fibers. The large fibers are used to form hooks, and the small fibers are used to form
loops, of the hook and loop fastener. The fibers are then weaved to form the
antimicrobial hook and loop fastener of the invention.
Example 2
Antimicrobial zeolite particles (Shinagawa AW-80) are mixed with a
solvent (water or acetone) in a concentration of 30% . The concentrate is then added to a
binder, which may comprise commonly used binders such as acrylic polymers, silicone,
urethane, or mixtures thereof to form a mixture. The mixture is adjusted to achieve final
load levels after evaporation of the solvent of from 0.1-10% by weight of the
antimicrobial zeolite particles . The mixture is then used to coat a previously formed hook
and loop fastener. The coating may be achieved by dipping, spraying or rolling the
fastener into the mixture.
E. Safety and Biocompatibility Data
The antimicrobial properties of the antimicrobial zeolite particles of the
invention may be assayed while in aqueous formulations using conventional assay techniques,
including for example determining the minimum growth inhibitory concentration (MIC) with
respect to a variety of bacteria, eumycetes and yeast. In such a test, the bacteria listed may
be employed:
Bacillus cereus varmycoides; Escherichia coli; Pseudomonas aeruginosa; Staphylococcus aureus; Streptococcus faecalis; Streptococcus mutans; Aspergillus niger; Aureobasidium pullulans; Chaetomium globosum; Gliocladium virens; Penicillum funiculosum; Candida albicans; and Saccharomyces cerevisiae.
The assay for determining MIC can be carried out by smearing a solution
containing bacteria for inoculation onto a plate culture medium to which a test sample of the
encapsulated antibiotic zeolite particles is added in a particular concentration, followed by
incubation and culturing of the plate. The MIC is defined as a minimum concentration
thereof required for inhibiting the growth of each bacteria.
Safety and Biocompatibility tests were conducted on the antimicrobial zeolites
employed in the invention. ISO 10993-1 procedures were employed. The following results
were obtained:
Cytotoxicity: Non-Toxic;
Acute Systemic Toxicity: Non-Toxic
Intracutaneous Toxicity: Passed
Skin Irritation Test: Non-Irritant
Chronic Toxicity: No Observable Effect
In-vitro Hemolysis: Non-Hemolytic
30-day Muscle Implant Test: Passed
60-day Muscle Implant Test: Passed
90-day Muscle Implant Test: Passed
Ames Mutagenicity Test: Passed
Pyrogenicity: Non-Pyrogenic
Thus, the antimicrobial zeolites are exceptionally suitable under relevant
toxicity and biocompatibility standards for use in a fastener.
While preferred embodiments of the invention have been described in the
foregoing examples, it will be understood by one skilled in the art that various changes
and modifications may be made therein without departing from the spirit and the scope of
the invention. All patent applications, patents, patent publications, and literature
references cited in this specification are hereby incorporated by reference in their
entirety. In the case of inconsistencies, the present description, including definitions, is
intended to control. Accordingly, the above description should be construed as
illustrating and not limiting the scope of the invention. All such obvious changes and
modifications are within the patented scope of the appended claims.